REG - ConvaTec Group PLC - Scrip Dividend - Total Issued Shares

ConvaTecAnnouncement

04/05/2022 15:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220504:nRSD3396Ka&default-theme=true

RNS Number : 3396K  ConvaTec Group PLC  04 May 2022

ConvaTec Group Plc

 

Scrip Dividend - Total Issued Shares

 

 

Reading, United Kingdom (4 May 2022)

The Board of Directors of ConvaTec Group Plc ("ConvaTec" or "the Company")
proposed a final dividend in respect of 2021 of 4.154 cents per share ("Final
Dividend"), subject to shareholder approval at the Annual General Meeting on
12 May 2022. The Final Dividend is to be paid on 19 May 2022 to shareholders
on the share register as at 1 April 2022 ("Record Date"). The dividend is
payable in cash in sterling to holders of ordinary shares. On 8 March 2022,
the Company announced that a scrip dividend would be made available in respect
of the Final Dividend, allowing shareholders to elect to receive their
dividend in the form of new ordinary shares. The calculation price for the
scrip dividend was announced on 7 April 2022.

It is confirmed that 7,192,010 new ordinary shares of 10 pence each will be
allotted and issued on 19 May 2022 by the Company to those shareholders who
elected to receive the scrip dividend alternative. The shares will rank pari
passu with the existing issued ordinary shares of the Company. Application
will be made to the Financial Conduct Authority for the shares to be admitted
to the Official List and to the London Stock Exchange for the shares to be
admitted to trading.

Following the issue of shares under the scrip dividend scheme in respect of
the Final Dividend, the Company's issued share capital will be 2,041,764,945
ordinary shares of 10 pence each.

Dealings in the shares issued under the scrip dividend scheme is expected to
commence on 19 May 2022.

 

Details of the scrip dividend scheme are available
at www.convatecgroup.com/investors (http://www.convatecgroup.com/investors) .

TIMETABLE

Key dates in respect of the scrip dividend scheme for the Final Dividend are:

 Ex-dividend Date                                                     31 March 2022
 Record Date                                                       1 April 2022
 Scrip calculation price determined                                31 March - 6 April 2022 (inclusive)
 Scrip calculation price available and announced                                              7 April 2022
 Mandate delivery deadline for Shares held in uncertificated form              3.00 p.m. on 27 April 2022
 Mandate delivery deadline for Shares held in certificated form    5.00 p.m. on 27 April 2022
   Announcement of the total amount of new shares to be issued                                         4 May
                                                                   2022
   Dividend payment date                                                                             19 May 2022
   Dispatch of statement in accordance with section 7 of Scheme                                      19 May 2022

Rules and share certificates, CREST accounts credited/updated,

and first day of dealings in New Shares

 
 

 

 

 

Enquiries

Analysts and Investors

Kate Postans, Vice President, Investor Relations
                                    +44
(0)7826 447 807
 
 

ir@convatec.com (mailto:ir@convatec.com)

 

Media

Buchanan: Charles Ryland / Chris Lane
                                    +44
(0)207 466 5000
 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on
therapies for the management of chronic conditions, with leading market
positions in advanced wound care, ostomy care, continence and critical care,
and infusion care. ConvaTec's products provide a range of clinical and
economic benefits including infection prevention, protection of at-risk skin,
improved patient outcomes and reduced total cost of care. To learn more about
ConvaTec, please visit www.convatecgroup.com (http://www.convatecgroup.com/)
where a copy of this announcement can also be found.

 

 

 

 

# # #

END

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFLSEFISIIF